Showing results (11-20 of 756) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|October 10, 2017
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 studyKarl Heinz Weiss, Frederick K Askari, Anna Czlonkowska, et al.
The Lancet. Gastroenterology & Hepatology|September 30, 2017
Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trialHoussam Halawi, Disha Khemani, Deborah Eckert, et al.
The Lancet. Gastroenterology & Hepatology|December 16, 2018
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trialNeil Gupta, Aimable Mbituyumuremyi, Jules Kabahizi, et al.
The Lancet. Gastroenterology & Hepatology|May 21, 2021
Breaking the therapeutic ceiling in drug development in ulcerative colitisDahham Alsoud, Bram Verstockt, Claudio Fiocchi, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint studyBrian G Feagan, William J Sandborn, Silvio Danese, et al.
The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.
The Lancet. Gastroenterology & Hepatology|August 31, 2025
The psychobiological model of disorders of gut-brain interaction: introduction of a novel, integrated, and testable modelLivia Guadagnoli, Lauren C Heathcote, Lukas Van Oudenhove, et al.
The Lancet. Gastroenterology & Hepatology|April 12, 2020
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trialViola Andresen, Jürgen Gschossmann, Peter Layer
The Lancet. Gastroenterology & Hepatology|August 13, 2021
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trialStephen Hanauer, Bernd Liedert, Sigrid Balser, et al.
The Lancet. Gastroenterology & Hepatology|April 20, 2020
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic periodMarietta Iacucci, Rosanna Cannatelli, Nunzia Labarile, et al.
Pageof 76